| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e8096642b0408c20bb7764569a0b54a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580265c2e0fee2c24140a43eca21f44b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68f7c47e3122482268852b59e29a18c |
| publicationDate |
2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2754352-A1 |
| titleOfInvention |
Postsynaptically targeted chemodenervation agents and their methods of use |
| abstract |
Improved chemodenervation agents are provided comprising polypeptide .alpha.-neurotoxins having high binding specificity and selectivity for the human muscular .alpha.1 nAChR instead of the human neuronal .alpha.7 nAChR, along with pharmaceutical compositions and methods of use. |
| priorityDate |
2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |